Stock market futures are up slightly. Enthusiasm has been tempered by geopolitical risks and uncertainty ahead of Wednesday’s Federal Reserve decision. The Fed is widely expected to hold rates steady, but investors are laser-focused on Chair Powell’s language regarding potential rate cuts later this year. Currently, markets are pricing in a roughly 56% chance of a quarter-point cut by September.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
In the background, rising tensions between Israel and Iran continue to cast a long shadow. Oil prices, although cooling slightly from last week’s surge, remain elevated. Analysts at RBC have warned that a prolonged crisis in the Middle East could trigger a significant market correction due to a combination of higher energy costs, weaker earnings expectations, and shaken investor sentiment.
In pre-market trading, S&P 500 futures rose 0.67%, Nasdaq futures rose 0.80% and Dow futures rose 0.64%.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
Also, The Fly has brought its right-to-the-point stock market reporting to YouTube! Subscribe if you want to know how the markets will open and what stocks traders will be focused on.
HIGHER –
- EchoStar (SATS) up 42% after Bloomberg reported President Donald Trump has intervened to urge EchoStar and Federal Communications Commission Chairman Brendan Carr to resolve a dispute over the company’s valuable spectrum licenses
- Sage Therapeutics (SAGE) up 35% after entering a definitive agreement for Supernus (SUPN) to acquire the company through a tender offer for $8.50 per share in cash, payable at closing, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash, for total consideration of $12.00 per share in cash
- Prothena (PRTA) up 10% after announcing partner Roche (RHHBY) will advance prasinezumab into Phase III development in early-stage Parkinson’s disease
- Roku (ROKU) up 9% after Amazon Ads (AMZN) and the company announced a new integration that gives advertisers access to the largest authenticated CTV footprint in the U.S.
- Victoria’s Secret (VSCO) up 7% after Bloomberg reported the company is being targeted by Barington Capital, who plans to urge the company to make changes to its board and strategy
- U.S. Steel (X) up 5% after the company and Nippon Steel (NPSCY) announced that President Trump has approved the companies’ partnership
- Hinge Health (HNGE) up 4% after Piper Sandler initiated coverage of Hinge with an Overweight rating among other firms starting coverage with bullish ratings
- MNTN (MNTN) up 4% after Loop Capital initiated coverage of MNTN with a Buy rating and other firms also started with bullish ratings
LOWER –
- Sarepta (SRPT) down 40% after suspending non-ambulatory Elevidys shipments following a second reported case of acute liver failure resulting in death, prompting several downgrades of the shares
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SAGE:
- Video: Sarepta, Hinge Health among major pre-market movers
- SAGE Therapeutics Announces Merger with Supernus Pharmaceuticals
- Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
- SAGE Therapeutics Approves Stock Plan Amendment
- SAGE Therapeutics: Hold Rating Maintained Amid Steady Growth and Strategic Uncertainties